Methionine EP Impurity D is a methionine-derived degradation species displaying altered oxidation state or side-chain rearrangement. These changes modify polarity, reactivity, and retention behavior. Researchers use it to understand oxidative pathways and confirm analytical robustness. Applications include impurity profiling, stability testing, and redox-mechanism studies.
CAT No: Z10-101-189
Synonyms/Alias:(2R)-2-[[(2RS)-2-(acetylamino)-4-(methylsulfanyl)butanoyl]amino]-4-(methylsulfanyl)butanoic acid; Ac-DL-Met-D-Met-OH; CY109S16ZI; METHIONINE IMPURITY D [EP IMPURITY]; (2R)-2-(((2RS)-2-(ACETYLAMINO)-4-(METHYLSULFANYL)BUTANOYL)AMINO)-4-(METHYLSULFANYL)BUTANOIC ACID
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.